Glenmark will sell remaining 7.84% stake in Glenmark Life Science (GLS) by doing an OFS.
This would amount to a pre-tax consideration of around 800 crores at 5% discount to CMP of GLS.
| Subscribe To Our Free Newsletter |
Glenmark – Will Innovation Pay?
